AU4347500A - Ubiquitin cross-reactive protein as a prognostic marker for tumor cell chemosensitivity - Google Patents

Ubiquitin cross-reactive protein as a prognostic marker for tumor cell chemosensitivity

Info

Publication number
AU4347500A
AU4347500A AU43475/00A AU4347500A AU4347500A AU 4347500 A AU4347500 A AU 4347500A AU 43475/00 A AU43475/00 A AU 43475/00A AU 4347500 A AU4347500 A AU 4347500A AU 4347500 A AU4347500 A AU 4347500A
Authority
AU
Australia
Prior art keywords
tumor cell
reactive protein
prognostic marker
ubiquitin cross
cell chemosensitivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43475/00A
Inventor
Shyamal D. Desai
Edmond J. Lavoie
Leroy Fong Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers State University of New Jersey
Original Assignee
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rutgers State University of New Jersey filed Critical Rutgers State University of New Jersey
Publication of AU4347500A publication Critical patent/AU4347500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
AU43475/00A 1999-04-13 2000-04-13 Ubiquitin cross-reactive protein as a prognostic marker for tumor cell chemosensitivity Abandoned AU4347500A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12906399P 1999-04-13 1999-04-13
US60129063 1999-04-13
US15774599P 1999-10-05 1999-10-05
US60157745 1999-10-05
PCT/US2000/009959 WO2000062075A1 (en) 1999-04-13 2000-04-13 Ubiquitin cross-reactive protein as a prognostic marker for tumor cell chemosensitivity

Publications (1)

Publication Number Publication Date
AU4347500A true AU4347500A (en) 2000-11-14

Family

ID=26827196

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43475/00A Abandoned AU4347500A (en) 1999-04-13 2000-04-13 Ubiquitin cross-reactive protein as a prognostic marker for tumor cell chemosensitivity

Country Status (2)

Country Link
AU (1) AU4347500A (en)
WO (1) WO2000062075A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003093493A2 (en) 2002-05-02 2003-11-13 Aspenbio, Inc. Pregnancy detection
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
US20100111874A1 (en) * 2007-03-19 2010-05-06 University Of Medicine And Dentistry Of New Jresey Method of cancer detection and treatment
LT2750768T (en) 2011-08-30 2019-02-11 Astex Pharmaceuticals, Inc. Decitabine derivative formulations
JP6768722B2 (en) 2015-07-02 2020-10-14 大塚製薬株式会社 Lyophilized pharmaceutical composition
CA3071755A1 (en) 2017-08-03 2019-02-07 Otsuka Pharmaceutical Co., Ltd. Drug compound and purification methods thereof

Also Published As

Publication number Publication date
WO2000062075A1 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
EP1226434B8 (en) Methods for performing magnetic chromatography assays
AU2003268089A1 (en) Method for identifying mhc-presented peptide epitopes for t cells
AU2002230527A1 (en) Mailer for cell culture apparatus
AU2002363046A1 (en) Method for erasing a memory cell
AU2001294520A1 (en) Methods and compositions for increasing protein yield from a cell culture
AU2002226882A1 (en) Improved cell carrier grids
AUPP856399A0 (en) Improved compounds for protein binding
AU2003220322A1 (en) Methods for identifying polypeptide factors interacting with rna
AU2003216822A1 (en) Stem cell culture
AU4347500A (en) Ubiquitin cross-reactive protein as a prognostic marker for tumor cell chemosensitivity
AU3243199A (en) Methods for assaying type iii secretion inhibitors
AU4697600A (en) Methods for increasing t cell proliferation
AU2001289943A1 (en) Complexes for transferring nucleic acids into cells
AU2002328803A1 (en) Marker for identifying hematopoietic stem cells
AU2002326036A1 (en) Method for determining cell cycle position
AU1882900A (en) Assay for homocysteine
AU3478599A (en) Cell cycle regulatory proteins
AU2002352778A1 (en) High-density cell microarrays for parallel functional determinations
AU2001258819A1 (en) Kit for assaying saccharified protein
AU2001276327A1 (en) Regulatory sequences from meristematic cells
AU4056500A (en) Methods for detecting cancer cells
AU5906099A (en) T cell peptides as therapeutics for immune-related disease
AU2001286053A1 (en) Cell assays
AU2003280362A1 (en) Reagent kit for cultivating cells
AU2002220412A1 (en) Methods involving a t cell protein tyrosine phosphatase

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase